Alkermes Plc reports results for the quarter ended June 30 - Earnings Summary
29/07/2025 14:31
Alkermes Plc ALKS.OQ reported quarterly adjusted earnings of 67 cents per share for the quarter ended June 30, lower than the same quarter last year, when the company reported EPS of 70 cents. The mean expectation of sixteen analysts for the quarter was for earnings of 40 cents per share. Wall Street expected results to range from 31 cents to 47 cents per share. Revenue fell 2.1% to $390.66 million from a year ago; analysts expected $341.56 million. Alkermes Plc's reported EPS for the quarter was 52 cents. The company reported quarterly net income of $87.1 million. Alkermes Plc shares had fallen by 8.6% this quarter and lost 9.1% so far this year. FORECAST CHANGES The mean earnings estimate of analysts had fallen by about 15.2% in the last three months. In the last 30 days, three analysts negatively revised earnings estimates RECOMMENDATIONS The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 12 "strong buy" or "buy," 5 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" Wall Street's median 12-month price target for Alkermes Plc is $42.00, about 37.7% above its last closing price of $26.15 This summary was machine generated from LSEG data July 29 at 01:31 p.m. UTC. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
| QUARTER ENDING | ESTIMATE | ACTUAL | BEAT, MET, MISSED |
| Jun. 30 2025 | 0.40 | 0.67 | Beat |
| Mar. 31 2025 | 0.23 | 0.27 | Beat |
| Dec. 31 2024 | 0.79 | 1.05 | Beat |
| Sep. 30 2024 | 0.74 | 0.72 | Missed |